Skip to main content
Cancer

Understanding GEP-NETs: What Are Gastroenteropancreatic Neuroendocrine Tumors?

Here’s what to know about GEP-NETs, a rare cancer that forms in the gastrointestinal tract.

Marisa Taylor KarasAlexandra Schwarz, MD
Written by Marisa Taylor Karas | Reviewed by Alexandra Schwarz, MD
Updated on July 3, 2024
Featuring Kimberly Perez, MDReviewed by Alexandra Schwarz, MD | July 3, 2024

You may not have heard of gastroenteropancreatic neuroendocrine tumors, or GEP-NETs. These are tumors that develop in the gastrointestinal tract. They are formed from neuroendocrine cells, which produce hormones and control many bodily functions. 

“We’ve developed multiple therapies over the last two decades which are [generally] well tolerated and very effective,” says Kimberly Perez, MD, Medical Oncologist with Dana-Farber Cancer Institute in Boston. 

What are neuroendocrine cells?

Neuroendocrine cells function as relay centers, meaning that they tell your body what to do in response to environmental stimuli. When neuroendocrine cells become abnormal and grow at an out-of-control rate, that’s when they become cancerous.

Rather than sending signals in response to stimuli, cancerous neuroendocrine cells will send random signals. 

What is carcinoid syndrome from a GEP-NET?

Sometimes this signaling causes symptoms of carcinoid syndrome, explains Perez. Carcinoid syndrome can include symptoms such as:

  • Diarrhea

  • Flushing

  • Stomach pain

  • Racing heart

  • Low appetite

  • Swelling

If you do experience any symptoms of carcinoid syndrome, make sure to tell your care team so that they can help treat it.

What should you know about GEP-NET treatment?

While it’s completely normal to feel overwhelmed after a GEP-NET diagnosis, Perez says that there are many great treatment options available.

“We’ll always be looking for better options for you to help manage your disease and make sure that your quality of life is maintained and improved as much as possible,” she says.

References

American Cancer Society. (2018). Treatment of gastrointestinal carcinoid tumors, by extent of disease

Cives, M., et al. (2018). Gastroenteropancreatic neuroendocrine tumors. CA: A Cancer Journal for Clinicians.

GoodRx Health has strict sourcing policies and relies on primary sources such as medical organizations, governmental agencies, academic institutions, and peer-reviewed scientific journals. Learn more about how we ensure our content is accurate, thorough, and unbiased by reading our editorial guidelines.

why trust our exports reliability shield

Why trust our experts?

Marisa Taylor Karas is a freelance journalist based in Brooklyn who has covered health, gender, and technology for 15 years. She previously worked at The Wall Street Journal, The Guardian, and Al Jazeera America, among other publications, and also served as managing editor of the Mellon Foundation in New York City.
Alexandra Schwarz, MD, is a board-eligible sleep medicine physician and a board-certified family medicine physician. She is a member of both the AASM and the ABFM.

Was this page helpful?

Latest articles